Paul Horn

Jena University Hospital — Germany

Arts and Humanities · Social Sciences

49h-index11.1kcitations461works70.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bach Studies and Logistics Development(72), Musicology and Musical Analysis(51), Liver Disease Diagnosis and Treatment(34), Historical, Literary, and Cultural Studies(31), Theoretical and Computational Physics(30)

Publications459 total

Macrophage heterogeneity and plasticity in liver injury and repair mechanisms
Stem Cells·2025
Metabolische Lebererkrankungen MASLD und MASH
CardioVasc·2025
A bioenergetic basis for multiorgan dysfunction in sepsis
2025
Diagnose und Therapie der MASLD
Die Innere Medizin·2025
FRI-078 Inflammation-educated macrophages drive exacerbated re-injury patterns via innate immune memory
Journal of Hepatology·2025
Key takeaways from the updated multidisciplinary European MASLD guidelines
eGastroenterology·2025· 10 citedOpen Access
Machine Learning Models predicting Decompensation in Cirrhosis
Journal of Gastrointestinal and Liver Diseases·2025· 5 citedOpen Access
2D, or not 2D? Investigating Vertical Signal Integrity of Tissue Slices
2025· 6 citedOpen Access
Pathomechanismen der hepatischen Fibrogenese
2025
Association of the Genetic Variant VEGFA rs3025039 with Incidence and Prognosis of Cholangiocarcinoma
Zeitschrift für Gastroenterologie·2025
Author response: Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis
2024Open Access
Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis
eLife·2024· 2 citedOpen Access
Publisher Correction: EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary
Diabetologia·2024· 4 citedOpen Access
Vorhersage der Dekompensation einer Leberzirrhose mithilfe maschinellen Lernens
Zeitschrift für Gastroenterologie·2024
Author response: Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis
2024Open Access
Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis
eLife·2024· 5 citedOpen Access
Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis
2024Open Access
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary
Diabetologia·2024· 113 citedOpen Access
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
Journal of Hepatology·2024· 1.2k citedOpen Access
Metabolic reprogramming in liver fibrosis
Cell Metabolism·2024· 236 citedOpen Access
page 1 of 23Next →

Frequent Co-authors

R. J. Birgeneau(16), Paul A. Heiney(10), D. E. Moncton(10), Peter W. Stephens(9), R. J. Birgeneau(7), G. A. Held(5), Mark Sutton(5), S. E. Nagler(5), Frank Tacke(4), Vincent Wai‐Sun Wong(3), Denis T. Keane(3), G. S. Brown(3), Roy Clarke(3), A. A. Mak(3), E. D. Specht(3), G. Shirane(3), T. F. Rosenbaum(3), S. G. J. Mochrie(3), Prashanta Dutta(2), Vlad Ratziu(2)